ZA942140B - Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy - Google Patents

Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy

Info

Publication number
ZA942140B
ZA942140B ZA942140A ZA942140A ZA942140B ZA 942140 B ZA942140 B ZA 942140B ZA 942140 A ZA942140 A ZA 942140A ZA 942140 A ZA942140 A ZA 942140A ZA 942140 B ZA942140 B ZA 942140B
Authority
ZA
South Africa
Prior art keywords
alpha
phenyl
useful
pyridineethanamine
therapy
Prior art date
Application number
ZA942140A
Other languages
English (en)
Inventor
Robert John Murray
Donald Mathisen
Michael Balestra
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB1993/000689 external-priority patent/WO1993020052A1/en
Application filed by Fisons Corp filed Critical Fisons Corp
Publication of ZA942140B publication Critical patent/ZA942140B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ZA942140A 1993-04-01 1994-03-25 Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy ZA942140B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1993/000689 WO1993020052A1 (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders

Publications (1)

Publication Number Publication Date
ZA942140B true ZA942140B (en) 1994-10-03

Family

ID=10728731

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA942140A ZA942140B (en) 1993-04-01 1994-03-25 Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy

Country Status (13)

Country Link
EP (1) EP0691958B1 (xx)
JP (1) JP3023988B2 (xx)
AT (1) ATE156814T1 (xx)
AU (1) AU682350B2 (xx)
CA (1) CA2159480C (xx)
DE (1) DE69404975T2 (xx)
DK (1) DK0691958T3 (xx)
ES (1) ES2105679T3 (xx)
FI (1) FI109019B (xx)
GR (1) GR3025082T3 (xx)
NO (1) NO304648B1 (xx)
WO (1) WO1994022832A1 (xx)
ZA (1) ZA942140B (xx)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422191A (en) * 1965-01-21 1969-01-14 Synergistics Inc Compositions and methods for tranquilization employing salts of n-morpholine ethanol
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
EP0648489A1 (en) * 1988-08-12 1995-04-19 Fisons Corporation Arylalkylamides having neuroprotective properties
JP2514855B2 (ja) * 1990-08-08 1996-07-10 キッセイ薬品工業株式会社 光学活性なアラニンアニリド誘導体の酸付加塩
PL180014B1 (pl) * 1992-04-03 2000-11-30 Astra Ab (S)- a-fenylo-2-pirydoetanoamina i kompozycja farmaceutyczna zawierajaca (S)- a-fenylo-2-pirydoetanoamine PL PL PL PL PL PL

Also Published As

Publication number Publication date
DK0691958T3 (da) 1997-12-08
WO1994022832A1 (en) 1994-10-13
DE69404975D1 (de) 1997-09-18
CA2159480A1 (en) 1994-10-13
DE69404975T2 (de) 1997-12-18
FI954646A0 (fi) 1995-09-29
NO953847L (no) 1995-11-22
EP0691958A1 (en) 1996-01-17
AU682350B2 (en) 1997-10-02
JP3023988B2 (ja) 2000-03-21
JPH08508475A (ja) 1996-09-10
GR3025082T3 (en) 1998-01-30
FI954646A (fi) 1995-11-29
EP0691958B1 (en) 1997-08-13
NO953847D0 (no) 1995-09-28
NO304648B1 (no) 1999-01-25
FI109019B (fi) 2002-05-15
CA2159480C (en) 2005-01-25
AU6433794A (en) 1994-10-24
ATE156814T1 (de) 1997-08-15
ES2105679T3 (es) 1997-10-16

Similar Documents

Publication Publication Date Title
AU1438295A (en) Method for treatment of papulo-pustules and comedones of the skin
AP9300555A0 (en) Therapeutic agent and its use
SG48204A1 (en) Salt of (s)-alpha-phenyl-2-pyridineethanamine useful in therapy
EP0858340A4 (en) COMBINATION THERAPY FOR TREATING DIABETES AND OBESITY
IL107768A0 (en) Treatment of agricultural produce
ZA942140B (en) Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
EP0733365A3 (en) Use of benzoquinolin-3-one for the treatment and prevention of prostate cancer
GB2280848B (en) Skin treatment apparatus
AU1192495A (en) Use of selegiline and its derivatives for the treatment of psoriasis
GB9312780D0 (en) Therapeutic and cosmetic treatment
LV10385B (en) Use of quinons in the treatment of cancer or aids
ZA964382B (en) Lymphotoxin and thrombopoietin for use in the treatment of cancer.
GB9303688D0 (en) Therapeutic treatment
ZA937015B (en) Treatment and diagnosis of cancer
IL106658A0 (en) Cancer diagnosis and treatment
EG19885A (en) Medicament for the treatment of hyperlipidaemia and/or atherosolerosis
LTIP581A (en) Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions
GB9310611D0 (en) Skin treatment
GB9213592D0 (en) Cancer prevention and therapy
BG98001U (en) Medicament for the treatment of hyperkeratotic conditions of the skin
GB9226313D0 (en) Therapeutic treatment
GEP19971009B (en) Flupirtine in combination with antiparkinsonica against muscle bracing
AU5381794A (en) Treatment and diagnosis of cancer